Member Info for BOTAK

Where is the operational description and roadmap ? , I could read more info off of the toilet paper in the office Bog , That rns is a disgrace

RNS out ! Without content , WTF is that Mr Crabb ?

Bob ,, Its our company ! ,, As a Non Significant shareholder I / We are not privy to BOD & company strategy ,sales or financials unless the latestor any rns content is fully descriptive and fully transparent as to company operations facts & Figures , We can only hope The BOD has the shareholders interest as a priority with shareholder value at the forefront of operations and strategy in line with growth & sucsess , That has most definitely been the case here @ Feedback plc for a number of years ( mushroom syndrome ), I personally make a point of liaising with current management and past Directors to hopefully gauge whether my money is in a dog or a possible multibagger, These Guy,s have been good enough to devote quite a considerable bit of time and effort to try an answer my queries and pacify my fears over the years so I have a deep Respect for the Management here ( and I include Trevor Brown in that sphere ) for not only their work @ feedback but their achievements gained in there own rights and Life,s Enough of paying homage ( Il put my tongue back in ! ) The next RNS should provide a roadmap for commercial viability and sustained growth to repay and reflect all the hard work of past Directors and the hard work of current BOD & Management but please please give us some shareholder value Should you doubt the integrity and ethics @ Feedback PLC , Just compare our team with the utter scum in charge at RBS who are a disgrace to there familys ,there country but above all themselves - http://citywire.co.uk/wealth-manager/rbs-admits-forging-grandmother-s-signature-in-mis-selling-scandal/a1093588?re=52701&ea=457809&utm_source=BulkEmail_WM_DailyWeekend&utm_medium=BulkEmail_WM_DailyWeekend&utm_campaign=BulkEmail_DailyWeekend Next week it is then !

Fair Comment Tobriand and some highly relevant issues , No point hiding under the pillows pretending the world is made of candy outside , The FACTS have not been that forthcoming thus far giving rise to " lack of transparency from the BOD comments " which imo has been well justified + the opportunity for various factions to undermine the sp for whatever reason and devaluing lth investments which is not so welcome , So if we are going to have a debate about the update let,s have an open honest one without hidden agenda,s which will be welcome and healthy

Whilst the below report is from another company not involved with TexRAD Research or Commercial ( to the best of my knowledge ) it seems the world is crying out for a combined Cadran / TexRAD technologies - AI will not replace Radiologists or other physicians, but in fact enhance and streamline their workflow even further by empowering them in their ecosystem, and help them make collaborative and intelligent decisions. If AI or Machine Learning is not embedded into the clinical workflow, the perceived benefits will not be realized. file:///home/chronos/u-d5ead7c310ba881fd1eed19a672f225c344068c7/Downloads/Augmented_Intelligence_The_Next_Frontier_(English_-_White_Paper).pdf Of course I stand to be corrected !

BG + Johann Sebastian Crabb should woo the clientele with ease !

Indeed El ! Viable Progress is the key, If we have a degree of encouraging sales to report with a clear roadmap to build up commercial viability than the rest is taboo ,,It will all fall into place including the SP ( despite the best efforts of our resident saboteur )

we have been waiting for this for 4 years, Try at least 6 years ! and there still pulling the same blag and the mugs are still falling for the same old Whilst the product might be viable , Do you really think the Saudis have not susseout Capt Jerk, offs ethics ? Take note of Sams wise remarks -I said it last week that the Board are disingenuous and nothing has changed to make me change my mind. http://www.lse.co.uk/share-regulatory-news.asp?shareprice=QFI&ArticleCode=333ed968&ArticleHeadline=MOA_Signed_with_Saudi_Arabian_Partner

A lump of Toxic waste even scabby street dogs would not sniff @, Every Dog has its day

Ur trade Just popped up on lse Profit , Not showing up on my other sites only the3 trades mentioned , Excellent Buy !

464k ???? I just got the 2 last rtades as 66.5K & 125.9k defo sell,s initial 30k a buy , our resident dumpster keeps rearing its ugly heard

What a disgusting lump of toxic waste he is

Of a total of 152 lung cancer patients analysed for heterogeneity, 124 (82%) were discussed at the MDT meeting. The TexRAD results were used for research purposes only and were not used to alter any individual patient�s treatment. The study suggests that there is a huge potential for the implementation of quantitative imaging in the assessment of tumour heterogeneity and engagement from radiologists is key to its success. Now to me that is a very positive statement HUGE POTENTIAL ! AR & DC today - Feedback plc (LON:FDBK) announced today that it has appointed David Crabb as chief executive officer (CEO) of the medical imaging company with immediate effect. The group said Crabb, most recently CEO of software company Cambridge Online Systems, has previously held director-level roles in medium-sized technology and outsourced solutions companies with revenues of between �50mln to over �1bn, with responsibilities including business optimisation, sales and marketing, and workforce leadership. WATCH: Feedback advancing clinical use of TexRAD after bagging CE mark It added that the appointment will underpin �the execution of the Company's growth strategy following the first CE marked release of TexRAD�; the Company's patented quantitative image texture analysis technology for diagnostic radiological scans.� Dr Alastair Riddell, Feedback's chairman, commented: �I am delighted that Feedback has attracted a highly experienced executive to complement the strong technical and regulatory expertise within the Company. Under David's leadership, we are well-positioned to leverage our pioneering technology to create evidence-based imaging software, arming clinicians with innovative tools to improve patient outcomes." READ: Feedback receives long-awaited CE mark for its TexRAD Lung software Feedback's new CEO added: "I am impressed with the platform technologies and domain expertise at Feedback�The opportunity is not without its challenges, as with all pioneering development, but as a small, ambitious company which has experienced both acquisition and organic growth, there is significant opportunity to optimise and expand Feedback's operations. "Our long-term vision is to lead global innovation in quantitative medical imaging analysis - I believe we have strong foundations to position ourselves at the forefront of this important field and I am looking forward to refining our strategy over the coming months."

https://t.co/dQdscuflIu

Excellent news , Will only be highly advantageous , Another cog in the wheel of progress , Bring on the interims !

Well done El , Just demonstrates the amount of data produced and paperwork written on the subject of CT Texture analysis, A section from the first link quotes a 6 years study Should TexRAD start selling in any large numbers and become entrenched as a go -to Medical Imaging tool for Texture Analysis on Lung,Liver,Colon,Breast.Brain etc then the competition has got a lot Proof Of Concept to undertake to become anywhere near a threat and actually just shows what a Joke FBDU,s pathetic attempt at buying into a medical software company to make headway into the market

Big WB just txd me again , telling me not to forget - "During such scary periods, you should never forget two things: First, widespread fear is your friend as an investor, because it serves up bargain purchases. Second, personal fear is your enemy. It will also be unwarranted."

I would assume so Coco but as always with Feedback plc us mushrooms can only await with bated breath

interims consisting of operational update before end of Feb or same as last year 20th

Well Well Well , Waddoyaknow eh ! Honest Trev -Feedback announces that it has been advised by Trevor Brown that following recent share sales, he is now beneficially interested in 26,539,111 ordinary shares of 0.25p each, representing 10.77 per cent of the issued ordinary shares of the Company.